Global Bio Stimulants Market Report 2022: Implementation of Organic Regulations Set to Bolster 23.3% Annual Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Bio stimulants Market Report Size, Trends & Growth Opportunity, By Active Ingredients, By Application, By Crop Type, By Region And Forecast Till 2027." report has been added to ResearchAndMarkets.com's offering.

The Global Bio stimulants was valued at US$ 1,280.45 Million in 2021, estimated to reach US$ 6,970.35 Million in 2027, with a CAGR of 23.33% from 2022-2027.

Any microorganism that applied to seeds, plants, or on the rhizosphere, stimulates natural processes to improve or benefit nutrient uptake, nutrient use efficiency, tolerance to abiotic stress, or crop quality and yield is called as Bio stimulants.

Market Drivers

Agricultural procedures are required to identify possible ways to be more efficient & effective in the coming decade. Bio stimulants can address this issue in a sustainable manner, by providing protection against stress & thereby propelling the growth of the plant.

The market for bio stimulants is anticipated to grow in the upcoming years, owing to the increase in consumer awareness about the benefits of organic foods, implementation of organic regulations, and adoption of Global Good Agricultural Practices (GLOBAL GAP) polices.

The use of organic & bio-based compounds in agriculture & forestry provides a significant opportunity for farmers to improve roots 7 shoot growth, stress resistance, and better growth potential. For instance, as per the information provided by the international federation of Organic Agriculture Movements & Research Institute of Organic Agriculture, in the year 2020, agricultural land under organic certification was around 3.14 million hectares in China.

The strong emphasis from governments & other stakeholders on the organic & sustainable mode of farming has raised the acceptance of these bio stimulants.

Market Restraints

Lack of transparency in patent protection laws in several countries has led to the prevalence of low-quality products.

The low prices of these products from small scale domestic manufacturers attracts farmers to purchase them which expected to hamper the growth of global bio stimulant market over the forecast period.

Industry development

In Nov 2021, Hanwha Solutions had announced a strategic investment in REC Silicon ASA to secure low-carbon photovoltaic materials amid growing demand for renewable energy in the USA. The company, which operates Q CELLS, agreed to invest in REC Silicon for $160.47 million, becoming a co-leading shareholder of the Biostimulant manufacturer with Aker Horizons, a Norway-headquartered investment firm focused on renewable energy.

In Oct 2020, Isagro S.p.A. communicates the Closing of the acquisition of 100% of Phoenix-Del S.r.l. capital stock was finalized. The value of the transaction amounts to €3.6 million, out of which 3.1 million paid Wednesday and 0.5 million to be paid in 2023 subject to the achievement of certain commercial objectives.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Bio stimulants Market Outlook

5 Bio stimulants Market, By Active Ingredients

6 Bio stimulants Market, By Crop Type

7 Bio stimulants Market, By Application

8 Bio stimulants Market, By Region

9 North America Bio stimulants Market Analysis and Forecast (2022-2027)

10 Europe Bio stimulants Market Analysis and Forecast (2022-2027)

11 Asia Pacific Bio stimulants Market Analysis and Forecast (2022-2027)

12 Latin America Bio stimulants Market Analysis and Forecast (2022-2027)

13 Middle East Bio stimulants Market Analysis and Forecast (2022-2027)

14 Competitive Analysis

15 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/gg3116